Invite a friend to get their first reward.Claim 1000 Satoshis

I'm searching

For Hoomans

You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.

Pioglitazone HCl-Glimepiride

Pioglitazone HCl-Glimepiride is a combination medication used to manage type 2 diabetes mellitus. This formulation combines pioglitazone, a thiazolidinedione, with glimepiride, a sulfonylurea, to help improve glycemic control in adults. The combination works synergistically to enhance insulin sensitivity and stimulate insulin secretion.

Rx. Enter your prescription

How would you like to get your prescription? Select an option

Pharmacy pickup

Select from 35,000 pharmacies

Free two-day delivery

Coming soon!

Find a pharmacy near you. Enter your ZIP code

Please enter your ZIP to find pharmacies near you.

Are you a member? Sign up or log in.

Sign up for free to start earning Bitcoin rewards

Get your personal savings card. Watch your Bitcoin balance grow and get paid whenever you want.

Sign Up

Access my personal savings card

Get instant savings at my pick-up pharmacy and earn bitcoin in my NiHowdy account

Log In
backgroundbackground

Members have saved

$NaN

using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!

NaNM

worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.

How much Bitcoin can you earn with Pioglitazone HCl-Glimepiride ?

The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.

See the value of your savings today

Today's Value

Bitcoin1 Bitcoin = $NaN

Bitcoin (BTC)

...

USD

$NaN

Adjust Bitcoin's potential value to see how much it could be worth

Potential Value

Bitcoin1 Bitcoin =

Bitcoin (BTC)

...

USD

$NaN

Frequently Asked Questions

How quickly does Pioglitazone HCl-Glimepiride start to work?
Open FAQClose FAQ

Patients may start to see improvements in their blood glucose levels within a few days of starting treatment, but it may take several weeks to achieve optimal control.

Can I stop taking Pioglitazone HCl-Glimepiride suddenly?
Open FAQClose FAQ

It is advisable to consult your healthcare provider before stopping the medication abruptly, as this could lead to an increase in blood glucose levels.

Are there any specific dietary restrictions while using Pioglitazone HCl-Glimepiride?
Open FAQClose FAQ

Patients should maintain a balanced diet and adhere to any dietary recommendations provided by their healthcare provider to support glycemic control.

What should I do if I miss a dose of Pioglitazone HCl-Glimepiride?
Open FAQClose FAQ

If you miss a dose, take it as soon as you remember. If it’s close to the time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.

Is Pioglitazone HCl-Glimepiride safe for long-term use?
Open FAQClose FAQ

Pioglitazone HCl-Glimepiride can be used long-term under medical supervision, but regular follow-up appointments are essential to monitor blood glucose levels, liver function, and any potential side effects.

Comprehensive Drug Guide

How Does Pioglitazone HCl-Glimepiride Work?

  • Pioglitazone works by activating peroxisome proliferator-activated receptor gamma (PPAR-γ), which increases insulin sensitivity in muscle and adipose tissue. This action helps to improve glucose uptake and utilization.
  • Glimepiride stimulates the pancreas to release more insulin by binding to sulfonylurea receptors on pancreatic beta cells. This enhances insulin secretion in response to elevated blood glucose levels.


Common Dosages

  • Tablets: Common strengths include combinations of 15 mg/2 mg, 30 mg/2 mg, and 30 mg/4 mg.

Typical Dosing

  • The usual recommended dose for adults is one tablet taken once daily, with or without food. The specific dosage may be adjusted based on the patient's blood glucose levels and tolerance.


Typical Dosing

FDA Approved Indications

Management of type 2 diabetes mellitus in conjunction with diet and exercise.

Who Shouldn't Take Pioglitazone HCl-Glimepiride?

  • Known hypersensitivity to pioglitazone, glimepiride, or any components of the formulation.
  • Severe heart failure or active bladder cancer.
  • Significant liver impairment or other severe liver disease.


Advice From The Pharmacist

  • Instruct patients to take Pioglitazone HCl-Glimepiride exactly as prescribed and to adhere to dietary and exercise recommendations.
  • Advise patients to monitor their blood glucose levels regularly and to report any significant changes or symptoms of hypoglycemia (such as dizziness, sweating, or confusion).
  • Discuss the importance of periodic liver function tests, especially if the patient has a history of liver disease.


Side Effects of Pioglitazone HCl-Glimepiride

Common Side Effects

  • Hypoglycemia (low blood sugar)
  • Weight gain
  • Edema (swelling)
  • Headache
  • Nasopharyngitis


Uncommon/Severe Side Effects

  • Heart failure exacerbation
  • Liver function abnormalities
  • Bladder cancer (associated with pioglitazone)


Risks and Warnings of Pioglitazone HCl-Glimepiride

  • Cardiovascular Risks: Monitor for signs of heart failure, especially in patients with a history of heart problems. Discontinue the medication if signs of heart failure develop.
  • Hypoglycemia: Patients should be educated on recognizing and managing hypoglycemic episodes, especially if they are taking other medications that lower blood sugar.


Interactions with Pioglitazone HCl-Glimepiride

Common Drug Interactions

  • Other Antidiabetic Medications: Caution should be exercised when using Pioglitazone HCl-Glimepiride with other antidiabetic agents, as this may increase the risk of hypoglycemia.
  • CYP2C9 Inhibitors: Medications that inhibit CYP2C9 may increase glimepiride levels, necessitating careful monitoring.


Alternatives to Pioglitazone HCl-Glimepiride

  • Other Diabetes Medications: Alternatives include other combinations of oral hypoglycemic agents, such as metformin with sulfonylureas or DPP-4 inhibitors, based on individual patient needs and glycemic control goals.